Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CMS Plans Guidance On “Best Price”; GAO Urges More Oversight Of Rebates

Executive Summary

The Centers for Medicare & Medicaid Services plans to offer guidance to manufacturers on how contracts with pharmacy benefit management companies should be analyzed in calculating Medicaid rebates

You may also be interested in...



Medicare Rx Risk-Sharing Deals Not Covered By Safe Harbors, Attorneys Say

Drug manufacturers and Medicare Part D drug plan sponsors may be misinterpreting the Medicare Modernization Act as they form risk-sharing arrangements, Sidley Austin Brown & Wood Partner William Sarraille told the Pharmaceutical Compliance Summit March 30 in Philadelphia

Medicare Rx Risk-Sharing Deals Not Covered By Safe Harbors, Attorneys Say

Drug manufacturers and Medicare Part D drug plan sponsors may be misinterpreting the Medicare Modernization Act as they form risk-sharing arrangements, Sidley Austin Brown & Wood Partner William Sarraille told the Pharmaceutical Compliance Summit March 30 in Philadelphia

Distribution Fees Remain Concern In ASP Reporting Despite CMS Clarification

The Centers for Medicare & Medicaid Services' position that bona fide service fees paid by manufacturers to wholesalers are exempt from average sales price calculations may not resolve problems with the fee-for-service distribution model, Sidley Austin Brown & Wood attorney William Sarraille said

Topics

UsernamePublicRestriction

Register

ID1122310

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel